Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 133-10-8
2. Sodium 4-amino-2-hydroxybenzoate
3. Sodium P-aminosalicylate
4. P-aminosalicylic Acid Sodium Salt
5. Sodium Pas
6. P-aminosalicylate Sodium
7. Bactylan
8. Sanipirol
9. Tubersan
10. Lepasen
11. Aminosalicylate Sodium
12. Aminosalicylate Sodium Anhydrous
13. Pamisyl Sodium
14. 4-aminosalicylic Acid Sodium Salt
15. Benzoic Acid, 4-amino-2-hydroxy-, Monosodium Salt
16. Sodium4-aminosalicylate
17. Sodium;4-amino-2-hydroxybenzoate
18. 8031-28-5
19. 4-amino-2-hydroxybenzoic Acid Sodium Salt
20. T9zkl3tnqf
21. Mls000069500
22. Chebi:2661
23. Sodium 2-hydroxy-4-aminobenzoate
24. Passodico
25. Smr000058602
26. Sodiopas
27. Nippas
28. Pasade
29. Pasnal
30. Salvis
31. Pasalon-rakeet
32. Natri-pas
33. Dsstox_cid_26066
34. Dsstox_rid_81316
35. Dsstox_gsid_46066
36. Sodium P-aminosalicylic Acid
37. Pas-na
38. Monosodium 4-amino-2-hydroxybenzoate
39. Cas-133-10-8
40. Monosodium T4-amino-2-hydroxybenzoate
41. Unii-t9zkl3tnqf
42. Ncgc00159472-02
43. Einecs 205-091-2
44. Aminosalicylate Sodium Anhydrous [usan]
45. Monopas
46. Sodium,4-amino-2-hydroxybenzoate
47. Sodium 4-amino-2-hydroxy-benzoate
48. Salicylic Acid, 4-amino-, Sodium Salt
49. Sodium P Aminosalicylate
50. 4-aminosalicylate Sodium
51. Opera_id_136
52. Para-aminosalicylate Sodium
53. Schembl688206
54. Spectrum1500116
55. Chembl1200966
56. Dtxsid0046066
57. Hms1920c11
58. Hms2091i11
59. Hms2230h22
60. Hms3371f03
61. Hms3652i08
62. Sodium 4-azanyl-2-oxidanyl-benzoate
63. Tox21_111696
64. Mfcd00064392
65. S4073
66. Akos006229752
67. Akos015963386
68. Anhydrous Sodium Aminosalicylate
69. Sodium Aminosalicylate [mart.]
70. Tox21_111696_1
71. Aminosalicylate Sodium [who-dd]
72. Ccg-212479
73. Ncgc00094584-01
74. Ncgc00094584-02
75. Ncgc00159472-05
76. Ac-19339
77. Ac-32474
78. A0423
79. Cs-0009515
80. Ft-0617610
81. Sw219149-1
82. C08055
83. Anhydrous Sodium Aminosalicylate [mart.]
84. A806557
85. Q27105758
86. F1905-7106
Molecular Weight | 175.12 g/mol |
---|---|
Molecular Formula | C7H6NNaO3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 1 |
Exact Mass | 175.02453734 g/mol |
Monoisotopic Mass | 175.02453734 g/mol |
Topological Polar Surface Area | 86.4 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 165 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Market Place
ABOUT THIS PAGE
88
PharmaCompass offers a list of Amino Salicylate Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amino Salicylate Sodium manufacturer or Amino Salicylate Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amino Salicylate Sodium manufacturer or Amino Salicylate Sodium supplier.
PharmaCompass also assists you with knowing the Amino Salicylate Sodium API Price utilized in the formulation of products. Amino Salicylate Sodium API Price is not always fixed or binding as the Amino Salicylate Sodium Price is obtained through a variety of data sources. The Amino Salicylate Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sodium 4-Aminosalicylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium 4-Aminosalicylate, including repackagers and relabelers. The FDA regulates Sodium 4-Aminosalicylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium 4-Aminosalicylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium 4-Aminosalicylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium 4-Aminosalicylate supplier is an individual or a company that provides Sodium 4-Aminosalicylate active pharmaceutical ingredient (API) or Sodium 4-Aminosalicylate finished formulations upon request. The Sodium 4-Aminosalicylate suppliers may include Sodium 4-Aminosalicylate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium 4-Aminosalicylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium 4-Aminosalicylate written confirmation (Sodium 4-Aminosalicylate WC) is an official document issued by a regulatory agency to a Sodium 4-Aminosalicylate manufacturer, verifying that the manufacturing facility of a Sodium 4-Aminosalicylate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sodium 4-Aminosalicylate APIs or Sodium 4-Aminosalicylate finished pharmaceutical products to another nation, regulatory agencies frequently require a Sodium 4-Aminosalicylate WC (written confirmation) as part of the regulatory process.
click here to find a list of Sodium 4-Aminosalicylate suppliers with Written Confirmation (WC) on PharmaCompass.
Sodium 4-Aminosalicylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium 4-Aminosalicylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium 4-Aminosalicylate GMP manufacturer or Sodium 4-Aminosalicylate GMP API supplier for your needs.
A Sodium 4-Aminosalicylate CoA (Certificate of Analysis) is a formal document that attests to Sodium 4-Aminosalicylate's compliance with Sodium 4-Aminosalicylate specifications and serves as a tool for batch-level quality control.
Sodium 4-Aminosalicylate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium 4-Aminosalicylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium 4-Aminosalicylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium 4-Aminosalicylate EP), Sodium 4-Aminosalicylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium 4-Aminosalicylate USP).